Prurigo Nodularis
Also known as: Nodularis Prurigo / Prurigo nodularis (disorder) / Neurodermatitis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12159 | Dupilumab | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB12159 | Dupilumab | Interleukin-4 receptor subunit alpha | target |
| DB12159 | Dupilumab | Interleukin-13 | target |
| DB12159 | Dupilumab | Interleukin-4 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08877 | Ruxolitinib | 1 | Recruiting | 1 |
| DB05676 | Apremilast | 1 / 2 | Unknown Status | 1 |
| DB14973 | Abrocitinib | 2 | Completed | 1 |
| DB05676 | Apremilast | 2 | Completed | 1 |
| DB00741 | Hydrocortisone | 2 | Completed | 1 |
| DB15252 | Nemolizumab | 2 | Completed | 1 |
| DB00337 | Pimecrolimus | 2 | Completed | 1 |
| DB12973 | Serlopitant | 2 | Completed | 1 |
| DB16350 | Vixarelimab | 2 | Completed | 1 |
| DB00844 | Nalbuphine | 2 / 3 | Completed | 3 |
| DB12159 | Dupilumab | 3 | Not Yet Recruiting | 1 |
| DB15252 | Nemolizumab | 3 | Active Not Recruiting | 1 |
| DB15252 | Nemolizumab | 3 | Completed | 3 |
| DB08877 | Ruxolitinib | 3 | Recruiting | 1 |
| DB12973 | Serlopitant | 3 | Completed | 2 |
| DB12973 | Serlopitant | 3 | Terminated | 1 |
| DB00281 | Lidocaine | 4 | Completed | 1 |
| DB00215 | Citalopram | Not Available | Unknown Status | 1 |
| DB12159 | Dupilumab | Not Available | Recruiting | 2 |
| DB01175 | Escitalopram | Not Available | Unknown Status | 1 |
| DB08895 | Tofacitinib | Not Available | Not Yet Recruiting | 1 |